Coronavirus | Covaxin to be sold at ₹600 to States
The Hindu
By comparison, Covishield, this week said their vaccines are priced at ₹400 for states and ₹600 for private hospitals
India's indigenously developed by Hyderabad based Bharat Biotech will be offered to State governments at ₹600 a dose and private hospitals at ₹1200 a dose, the company said in a statement late Saturday. By comparison, Covishield, this week said their vaccines are priced at ₹400 for states and ₹600 for private hospitals. From May 1, vaccines are expected to be available for everyone over 18. COVAXIN, the company said, will be exported at $15-20 a dose.
Trump's Iran tariff threat poses limited risk to India's trade, affecting only select sectors like rice and fresh fruits.
Trump said on Monday that Microsoft will make “major changes” this week to ensure U.S. consumers do not pay more for electricity because of data centres’ power consumption
Stock markets decline after initial gains due to foreign fund outflows and blue-chip selling, highlighting key laggards like TCS and HCL Tech.
The rupee declines to 90.22 against the dollar, influenced by global trade uncertainties and rising crude oil prices.
Google parent Alphabet Inc. on Monday became the fourth Big Tech powerhouse to be valued at $4 trillion
Fed's Williams emphasizes a favorable economic outlook, asserting monetary policy is well-positioned to balance inflation and job market stability.
As India’s solar energy capacity continues to accelerate, the domestic industry is seeking an enhanced Production-linked incentive scheme, second instalment of PM-Kusum and viability gap funding to accelerate potential for energy storage, in the upcoming Union Budget.
HCL Tech, a Noida-based tech firm promoted by Shiv Nadar, on Monday posted third-quarter net profit of ₹4,076 crore, a 11% decline from ₹4,591 crore it reported a year earlier.
Public sector banks appeal against a stay on fraud classification proceedings against Anil Ambani, citing legal flaws in interim relief.
Sensex rebounds 300 points after five-day decline, driven by bargain hunting amid geopolitical tensions and foreign fund outflows.
BSE warns investors about a fraudulent deepfake video of its CEO offering unauthorized stock recommendations on social media.
Rupee recovers 2 paise to close at 90.16 against the dollar amid improved market sentiment and trade deal discussions.
Maruti Suzuki approves ₹35,000 crore second plant in Gujarat, aiming for 10 lakh units annually by FY29.